← Leaderboards
Benjamin D Philpot
Univ Of North Carolina Chapel Hill
$13,874,681
Attributed
$21,876,317
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2007–25$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,876,317 · 11
By mechanism
R01$17,278,341 · 8
T32$3,783,726 · 1
R56$544,250 · 1
R25$270,000 · 1
Top collaborators
- Mark J Zylka12 shared
- Heather Cody Hazlett6 shared
- Joseph Piven6 shared
- Jeffrey Aube3 shared
- Leon Garland Coleman2 shared
- Jonathan C. Schisler2 shared
- Mark D Shen2 shared
- Mark W. Shen1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Jason Louis Stein$14,331,218
- Mark J Zylka$33,948,391
- Sheryl S Moy$6,410,060
- Stephanie M Engel$20,689,698
- Weili Lin$21,939,114
Others in their field
Top investigators on “Adult”
- Lawrence Corey · Fred Hutchinson Cancer Center$594,628,824
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$397,114,680
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$388,038,550
- Judith S. Currier · University Of California Los Angeles$251,592,913
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$196,603,707
- Carol Nesel · Westat$188,148,170
Research focus
AdultNeuronsNeurodevelopmental DisorderPostnatalMouse ModelBrainAllelesLeadPhenotypeLifeAutism Spectrum DisorderPathway InteractionsBehavioralMutationClinical TrialsGenesProteinsSpeechLinkIntellectual Functioning DisabilityCellsElectrophysiology (Science)Angelman SyndromeFunctional Disorder
Grant awards (52)
Small Molecule Therapeutic Discovery for Angelman Syndrome$575,490
R01 · FY2025 · NS · contact PI
Postdoctoral Research in Neurodevelopmental Disorders$533,062
T32 · FY2025 · HD · contact PI
Investigating UBE3A as a driver gene in Duplication 15q syndrome$363,931
R01 · FY2025 · NS · contact PI
CAROLINA SUMMER FELLOWS PROGRAM IN NEUROPHARMACOLOGY AND NEUROBIOLOGICAL DISEASES (CSF-NEURO)$135,000
R25 · FY2025 · NS
Small Molecule Therapeutic Discovery for Angelman Syndrome$558,226
R01 · FY2024 · NS · contact PI
Postdoctoral Research in Neurodevelopmental Disorders$476,795
T32 · FY2024 · HD · contact PI
Investigating UBE3A as a driver gene in Duplication 15q syndrome$392,239
R01 · FY2024 · NS · contact PI
CAROLINA SUMMER FELLOWS PROGRAM IN NEUROPHARMACOLOGY AND NEUROBIOLOGICAL DISEASES (CSF-NEURO)$135,000
R25 · FY2024 · NS
UBE3A gain-of-function and parent-of-origin influence on neurodevelopmental phenotypes$648,365
R01 · FY2023 · MH
Small Molecule Therapeutic Discovery for Angelman Syndrome$575,490
R01 · FY2023 · NS · contact PI
Postdoctoral Research in Neurodevelopmental Disorders$442,016
T32 · FY2023 · HD · contact PI
Investigating UBE3A as a driver gene in Duplication 15q syndrome$422,518
R01 · FY2023 · NS · contact PI
TCF4 in Pitt-Hopkins syndrome$337,260
R01 · FY2023 · NS · contact PI
UBE3A gain-of-function and parent-of-origin influence on neurodevelopmental phenotypes$648,365
R01 · FY2022 · MH
White Matter Pathology in Angelman Syndrome and Its Potential as an Outcome Measure in Clinical Trials$587,533
R01 · FY2022 · HD · contact PI
TCF4 in Pitt-Hopkins syndrome$337,260
R01 · FY2022 · NS · contact PI
Postdoctoral Research in Neurodevelopmental Disorders$325,293
T32 · FY2022 · HD
UBE3A gain-of-function and parent-of-origin influence on neurodevelopmental phenotypes$671,160
R01 · FY2021 · MH
White Matter Pathology in Angelman Syndrome and Its Potential as an Outcome Measure in Clinical Trials$595,604
R01 · FY2021 · HD · contact PI
Postdoctoral Research in Neurodevelopmental Disorders$428,144
T32 · FY2021 · HD
TCF4 in Pitt-Hopkins syndrome$337,260
R01 · FY2021 · NS · contact PI
UBE3A gain-of-function and parent-of-origin influence on neurodevelopmental phenotypes$700,632
R01 · FY2020 · MH
White Matter Pathology in Angelman Syndrome and Its Potential as an Outcome Measure in Clinical Trials$612,696
R01 · FY2020 · HD · contact PI
Postdoctoral Research in Neurodevelopmental Disorders$454,926
T32 · FY2020 · HD
TCF4 in Pitt-Hopkins syndrome$337,260
R01 · FY2020 · NS · contact PI
UBE3A gain-of-function and parent-of-origin influence on neurodevelopmental phenotypes$684,940
R01 · FY2019 · MH
White Matter Pathology in Angelman Syndrome and Its Potential as an Outcome Measure in Clinical Trials$621,084
R01 · FY2019 · HD · contact PI
Postdoctoral Research in Neurodevelopmental Disorders$354,759
T32 · FY2019 · HD
TCF4 in Pitt-Hopkins syndrome$337,260
R01 · FY2019 · NS · contact PI
White Matter Pathology in Angelman Syndrome and Its Potential as an Outcome Measure in Clinical Trials$627,537
R01 · FY2018 · HD · contact PI
Postdoctoral Research in Neurodevelopmental Disorders$367,628
T32 · FY2018 · HD
White Matter Fiber Tract Pathology in a Genetically-Defined Neurodevelopmental Disorder$544,250
R56 · FY2017 · NS · contact PI
Postdoctoral Research in Neurodevelopmental Disorders$401,103
T32 · FY2017 · HD
Role of UBE3A in the Central Nervous System$321,269
R01 · FY2017 · NS · contact PI
Epigenetic Regulation of Ube3a as a Treatment for Angelman Syndrome$591,194
R01 · FY2016 · MH · contact PI
Role of UBE3A in the Central Nervous System$321,269
R01 · FY2016 · NS · contact PI
Epigenetic Regulation of Ube3a as a Treatment for Angelman Syndrome$589,741
R01 · FY2015 · MH · contact PI
Role of UBE3A in the Central Nervous System$321,269
R01 · FY2015 · NS · contact PI
Epigenetic Regulation of Ube3a as a Treatment for Angelman Syndrome$607,649
R01 · FY2014 · MH · contact PI
Role of UBE3A in the Central Nervous System$321,269
R01 · FY2014 · NS · contact PI
Epigenetic Regulation of Ube3a as a Treatment for Angelman Syndrome$678,041
R01 · FY2013 · MH · contact PI
Epigenetic Regulation of Ube3a as a Treatment for Angelman Syndrome$94,681
R01 · FY2013 · MH · contact PI
Epigenetic Regulation of Ube3a as a Treatment for Angelman Syndrome$614,344
R01 · FY2012 · MH · contact PI
Epigenetic Regulation of Ube3a as a Treatment for Angelman Syndrome$32,524
R01 · FY2012 · MH · contact PI
Mechanisms of Presynaptic Plasticity in Visual Cortex$311,634
R01 · FY2011 · EY · contact PI
Mechanisms of Presynaptic Plasticity in Visual Cortex$366,622
R01 · FY2010 · EY · contact PI
Mechanisms of Presynaptic Plasticity in Visual Cortex$44,440
R01 · FY2010 · EY · contact PI
Mechanisms of Presynaptic Plasticity in Visual Cortex$320,019
R01 · FY2009 · EY · contact PI
Mechanisms of Presynaptic Plasticity in Visual Cortex$101,721
R01 · FY2009 · EY · contact PI
Mechanisms of Presynaptic Plasticity in Visual Cortex$310,913
R01 · FY2008 · EY · contact PI
Mechanisms of Presynaptic Plasticity in Visual Cortex$42,213
R01 · FY2008 · EY · contact PI
Mechanisms of Presynaptic Plasticity in Visual Cortex$315,419
R01 · FY2007 · EY · contact PI